-
21Comparison of the metabolic and economic consequences of long‐term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost‐effectiveness analysisJournal of Evaluation in Clinical Practice 16 (4): 744-755. 2010.
Leeds, West Yorkshire, United Kingdom of Great Britain and Northern Ireland